Search

Blythe G Thomson

age ~57

from Cincinnati, OH

Get Report
Also known as:
  • Blythe Scott Thomson
  • Blythe G T Sutherland
  • Blythe Thompson
  • Grace Thomson Blythe
Related to:
Connected to:

Blythe Thomson Phones & Addresses

  • Cincinnati, OH
  • Vonore, TN
  • Chestnut Hill, MA
  • 16 Fredette Rd, Newton Center, MA 02459
  • Newton, MA
  • 433 Sky Country Way NW, Issaquah, WA 98027
  • Seattle, WA
  • Loveland, OH
  • Indianapolis, IN
  • Hamilton, OH
  • Worthington, OH

Work

  • Company:
    SEATTLE CHILDRENS HOSPITAL
  • Address:
    4800 Sand Point Way Ne, Seattle, WA 98105
  • Phones:
    206 987-2000

Education

  • School / High School:
    Ohio State University / College of Medicine
    1992

Languages

English

Awards

Healthgrades Honor Roll

Ranks

  • Certificate:
    Pediatric Oncology & Pediatric Hematology, 2008

Specialities

Pediatric Hematology & Oncology

Medicine Doctors

Blythe Thomson Photo 1

Dr. Blythe Thomson, Seattle WA - MD (Doctor of Medicine)

view source
Specialties:
Pediatric Hematology & Oncology
Address:
SEATTLE CHILDRENS HOSPITAL
4800 Sand Point Way Ne, Seattle, WA 98105
206 987-2000 (Phone)

Seattle Childrens Hmtlgy/Onclgy
4800 Sand Point Way Ne Suite Mb8.50, Seattle, WA 98105
206 987-2106 (Phone)
Certifications:
Pediatric Oncology & Pediatric Hematology, 2008
Pediatrics, 2003
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Ohio State University / College of Medicine
Graduated: 1992
Medical School
Oh State U
Graduated: 1992
Medical School
U Of Washington
Graduated: 1992
Blythe Thomson Photo 2

Blythe Thomson, Seattle WA

Work:
Seattle Children's Hospital
4800 Sand Point Way NE, Seattle, WA 98105
Name / Title
Company / Classification
Phones & Addresses
Blythe Thomson
Doctor Of Medicine
Childrens Hospital and Regional Medical Center
Medical Laboratories
4800 Sand Point Way Ne Stop 6D-1, Seattle, WA 98105
Blythe Thomson
Doctor Of Medicine
Children's Hospital And Regional Medical Center
Medical Laboratories · Specialty (except Psychiatric and Substance Abuse) Hospitals
4800 Sand Pt Way NE, Seattle, WA 98105
6901 Sand Pt Way NE, Seattle, WA 98115
206 987-2000, 206 987-2253, 206 987-1426
Blythe Grace Thomson
Blythe Thomson MD
Pediatric Oncologist · Pediatrician · Internist
4800 Sand Pt Way NE, Seattle, WA 98105
206 987-2106

Us Patents

  • Inhibiting Mutant Isocitrate Dehydrogenase 1 (Midh-1)

    view source
  • US Patent:
    20230066088, Mar 2, 2023
  • Filed:
    Mar 21, 2022
  • Appl. No.:
    17/700027
  • Inventors:
    - Watertown MA, US
    Susan Ashwell - Carlisle MA, US
    Blythe Thomson - Cincinnati OH, US
    Alan Collis - Lexington MA, US
    Jeff Davis - Hingham MA, US
    Duncan Walker - Boulder CO, US
    Wei Lu - Newton MA, US
  • International Classification:
    A61K 31/4709
    A61P 35/00
  • Abstract:
    Patients diagnosed with a cancer harboring an IDH-1 mutation can be treated by the administration of a therapeutically effective amount of a pharmaceutical composition comprising Compound 1, a selective inhibitor of 2-HG production from mIDH-1 enzymes including the R132 mutations R132C, R132H, R132L, R132G, and R132S.

  • Inhibiting Mutant Isocitrate Dehydrogenase 1 (Midh-1)

    view source
  • US Patent:
    20210244727, Aug 12, 2021
  • Filed:
    Apr 28, 2021
  • Appl. No.:
    17/243177
  • Inventors:
    - Watertown MA, US
    Blythe THOMSON - Cincinnati OH, US
    Patrick F. KELLY - Concord MA, US
    Alan COLLIS - Lexington MA, US
    Jeff DAVIS - Hingham MA, US
    Duncan WALKER - Boulder CO, US
    Wei LU - Newton MA, US
  • International Classification:
    A61K 31/4709
    A61K 31/706
    A61P 35/00
    A61P 35/02
  • Abstract:
    Patients diagnosed with a cancer harboring an IDH-1 mutation can be treated by the administration of a therapeutically effective amount of a pharmaceutical composition comprising Compound 1, a selective inhibitor of 2-HG production from mIDH-1 enzymes including the R132 mutations R132C, R132H, R132L, R132G, and R132S.

  • Treating Patients Harboring An Isocitrate Dehydrogenase 1 (Idh-1) Mutation

    view source
  • US Patent:
    20210085669, Mar 25, 2021
  • Filed:
    Dec 4, 2020
  • Appl. No.:
    17/112269
  • Inventors:
    - Watertown MA, US
    Alan Collis - Lexington MA, US
    Jeff Davis - Hingham MA, US
    Duncan Walker - Boulder CO, US
    Susan Ashwell - Carlisle MA, US
    Blythe Thomson - Cincinnati OH, US
    Wei Lu - Newton MA, US
  • International Classification:
    A61K 31/4709
    A61P 35/02
    C12Q 1/686
    C12Q 1/6886
  • Abstract:
    Methods of treating patients diagnosed with AML or MDS harboring mutant IDH-1 include detecting an IDH1 mutation and the therapeutic administration of an inhibitor of a mutant IDH-1 as a single agent, or in combination with azacitidine (AZA) or cytarabine.

  • Inhibiting Mutant Idh-1

    view source
  • US Patent:
    20200108060, Apr 9, 2020
  • Filed:
    Nov 25, 2019
  • Appl. No.:
    16/693585
  • Inventors:
    - Watertown MA, US
    Alan Collis - Lexington MA, US
    Jeff Davis - Hingham MA, US
    Duncan Walker - Boulder CO, US
    Susan Ashwell - Carlisle MA, US
    Blythe Thomson - Newton MA, US
  • International Classification:
    A61K 31/4709
    A61P 35/00
    A61K 9/00
  • Abstract:
    Methods of treating patients diagnosed with cancer harboring an IDH-1 mutation are provided, including the therapeutic administration of a certain inhibitor of a mutant IDH-1 as a single agent, or in combination with azacitidine (AZA).

  • Treatment Of Leukemia Via The Administration Of Dot1L Inhibitor Pinometostat

    view source
  • US Patent:
    20200009176, Jan 9, 2020
  • Filed:
    May 17, 2019
  • Appl. No.:
    16/415325
  • Inventors:
    - Cambridge MA, US
    Scott R. DAIGLE - Newburyport MA, US
    Eric HEDRICK - Summit NJ, US
    Nigel WATERS - Belmont MA, US
    Blythe THOMSON - Newton MA, US
  • International Classification:
    A61K 31/7076
    A61P 35/02
  • Abstract:
    The present invention relates to DOT1L inhibitors. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating disorders in which DOT1-mediated protein methylation plays a part, such as cancer, by administering these compounds and pharmaceutical compositions to subjects in need thereof

  • Inhibiting Mutant Idh-1

    view source
  • US Patent:
    20190350919, Nov 21, 2019
  • Filed:
    May 16, 2019
  • Appl. No.:
    16/414505
  • Inventors:
    - Watertown MA, US
    Alan Collis - Lexington MA, US
    Jeff Davis - Hingham MA, US
    Duncan Walker - Boulder CO, US
    Susan Ashwell - Carlisle MA, US
    Blythe Thomson - Newton MA, US
  • International Classification:
    A61K 31/4709
    A61K 9/00
    A61P 35/00
  • Abstract:
    Methods of treating patients diagnosed with cancer harboring an IDH-1 mutation are provided, including the therapeutic administration of a certain inhibitor of a mutant IDH-1 as a single agent, or in combination with azacitidine (AZA).

  • Treatment Of Leukemia Via The Administration Of Dot1L Inhibitor Pinometostat

    view source
  • US Patent:
    20190076455, Mar 14, 2019
  • Filed:
    Dec 4, 2015
  • Appl. No.:
    15/533205
  • Inventors:
    - Cambridge MA, US
    Scott R. DAIGLE - Newburyport MA, US
    Eric HEDRICK - Summit NJ, US
    Nigel WATERS - Belmont MA, US
    Blythe THOMSON - Newton MA, US
  • International Classification:
    A61K 31/7076
    A61P 35/02
  • Abstract:
    The present invention relates to a method for the treatment of leukemia and the induction of leukemic blast cell maturation or differentiation via the administration of the DOT1L inhibitor pinometostat (otherwise known as EPZ-5676; CAS Registry number 1380288-87-8) or its N-oxide or pharmaceutically acceptable salt thereof.

  • Methods For Treating Cancer

    view source
  • US Patent:
    20160296548, Oct 13, 2016
  • Filed:
    Nov 13, 2014
  • Appl. No.:
    15/036544
  • Inventors:
    - Cambridge MA, US
    Scott R. Daigle - Newburyport MA, US
    Eric Hedrick - Summit NJ, US
    Nigel Waters - Belmont MA, US
    Blythe Thomson - Newton MA, US
  • International Classification:
    A61K 31/7076
  • Abstract:
    The present invention relates to DOT1L inhibitors. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating disorders in which DOT1-mediated protein methylation plays a part, such as cancer, by administering these compounds and pharmaceutical compositions to subjects in need thereof.

Youtube

Colin Blythe dedication ceremony

Colin Blythe dedication ceremony

Dedication of a cricket bat at the grave-side of Colin Blythe, cricket...

  • Category:
    People & Blogs
  • Uploaded:
    11 Dec, 2010
  • Duration:
    5m 48s

What I Really Meant to Say Anne & Gil

What I Really Meant to Say Anne & Gil

The song is "What I Really Meant to Say" by Cyndi Thomson. The charact...

  • Category:
    Film & Animation
  • Uploaded:
    09 Jun, 2007
  • Duration:
    3m 15s

"Waiting For Forever" Premiere Tom Sturridge ...

"Waiting For Forever" Premiere Tom Sturridge and R...

Maximo TV - License this clip www.maximotv.com http Rachel Bilson, Tom...

  • Category:
    Entertainment
  • Uploaded:
    02 Feb, 2011
  • Duration:
    9m 19s

The cast of 'Anne with an E' plays Jam or Not...

The cast of 'Anne with an E' plays Jam or Not a Jam

"It's not great music, but it's really lovely to listen to..." We gave...

  • Duration:
    2m 6s

Fighting Men of Rhodesia ep98 | Sqn. Ldr. Joh...

Fighting Men of Rhodesia ep98 | Sqn. Ldr. John Bly...

Squadron Leader John Blythe-Wood, BCR, was a pilot who participated in...

  • Duration:
    40m 28s

Gene Editing Interview

Gene Editing Interview

Chair: Blythe Thomson, M.D., Senior Director, Medical Affairs, Hematol...

  • Duration:
    42m 44s

Blythe Winner

Blythe Winner

Music from Uppbeat (free for Creators!): "Can't Stop Chasing you"

  • Duration:
    4m 1s

Anne with an E Cast Names and Real Age 2019

Anne with an E Cast Names and Real Age 2019

Amybeth McNulty ... Anne Shirley-Cuthbert Geraldine James ... Marilla ...

  • Duration:
    3m 18s
Get Report for Blythe G Thomson from Cincinnati, OH, age ~57
Control profile